A detailed history of Hartford Investment Management CO transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Hartford Investment Management CO holds 3,270 shares of CRL stock, worth $646,642. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,270
Previous 3,309 1.18%
Holding current value
$646,642
Previous $683,000 5.71%
% of portfolio
0.02%
Previous 0.02%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$187.96 - $245.29 $7,330 - $9,566
-39 Reduced 1.18%
3,270 $644,000
Q2 2024

Aug 01, 2024

SELL
$206.39 - $268.73 $2,889 - $3,762
-14 Reduced 0.42%
3,309 $683,000
Q1 2024

Apr 17, 2024

SELL
$203.52 - $273.43 $29,306 - $39,373
-144 Reduced 4.15%
3,323 $900,000
Q4 2023

Jan 23, 2024

SELL
$164.52 - $238.84 $17,439 - $25,317
-106 Reduced 2.97%
3,467 $819,000
Q3 2023

Oct 16, 2023

SELL
$194.44 - $217.61 $16,138 - $18,061
-83 Reduced 2.27%
3,573 $700,000
Q2 2023

Jul 19, 2023

SELL
$183.71 - $210.25 $130,801 - $149,698
-712 Reduced 16.3%
3,656 $768,000
Q1 2023

May 09, 2023

BUY
$191.89 - $259.92 $118,204 - $160,110
616 Added 16.42%
4,368 $881,000
Q4 2022

Jan 20, 2023

SELL
$197.11 - $250.07 $228,844 - $290,331
-1,161 Reduced 23.63%
3,752 $818,000
Q3 2022

Nov 02, 2022

BUY
$182.44 - $250.54 $1,459 - $2,004
8 Added 0.16%
4,913 $967,000
Q2 2022

Jul 22, 2022

BUY
$204.13 - $302.4 $16,942 - $25,099
83 Added 1.72%
4,905 $1.05 Million
Q1 2022

Apr 20, 2022

SELL
$255.51 - $362.11 $99,904 - $141,585
-391 Reduced 7.5%
4,822 $1.37 Million
Q4 2021

Feb 02, 2022

BUY
$351.38 - $448.68 $144,768 - $184,856
412 Added 8.58%
5,213 $1.96 Million
Q3 2021

Nov 01, 2021

SELL
$372.64 - $458.3 $207,560 - $255,273
-557 Reduced 10.4%
4,801 $1.98 Million
Q2 2021

Jul 29, 2021

BUY
$294.17 - $371.65 $1.58 Million - $1.99 Million
5,358 New
5,358 $1.98 Million
Q1 2019

Apr 29, 2019

SELL
$104.82 - $146.73 $318,862 - $446,352
-3,042 Closed
0 $0
Q3 2018

Nov 08, 2018

SELL
$112.11 - $134.54 $22,758 - $27,311
-203 Reduced 6.26%
3,042 $409,000
Q2 2018

Jul 19, 2018

BUY
$102.37 - $117.25 $332,190 - $380,476
3,245 New
3,245 $364,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Hartford Investment Management CO Portfolio

Follow Hartford Investment Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hartford Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Hartford Investment Management CO with notifications on news.